Post-Vaccine PD-L1 Conversion Test for Cold Tumors

A pathology test comparing PD-L1 on tumor tissue before and after mRNA vaccination, identifying 'cold' tumor patients whose tumors have converted into checkpoint-inhibitor candidates.